Skip to main content

Public Plans

Public plans are plans created using the DMP Tool service and shared publicly by their owners. They are not vetted for quality, completeness, or adherence to funder guidelines.

Plans (105)

NIH DMS Plan Format 2023 Version (Allowed for due dates prior to May 25th, 2026)

Functional Outcomes in Conduction System Pacing

Ajay Pillai, Virginia Commonwealth University (vcu.edu)
NIH DMS Plan Format 2023 Version (Allowed for due dates prior to May 25th, 2026)

Target trial emulation of nonoperative versus operative management of acute appendicitis for older patients

Courtney Balentine, University of Wisconsin–Madison (wisc.edu)
NIH DMS Plan Format 2023 Version (Allowed for due dates prior to May 25th, 2026)

Impact of Early-life Exposure to Semi-Volatile Organic Compounds (SVOCs) on Neonatal and Early Childhood Immune Function

Jennifer Hoffman, Duke University (duke.edu)
NIH DMS Plan Format 2023 Version (Allowed for due dates prior to May 25th, 2026)

Unraveling the Complexities of Risk and Mechanism in Cancer

John Quackenbush, Harvard University (harvard.edu)
NIH DMS Plan Format 2023 Version (Allowed for due dates prior to May 25th, 2026)

Law Enforcement Drug Seizures and Homeless Encampment Displacements: Implications for Overdose Risk

Bradley Ray, RTI International (rti.org)
NIH-Default DMSP

Increasing Trial Enrollment of Rural Residents in ARDS Clinical Trials

Marie Nguyen, University of Nebraska Medical Center (unmc.edu)
NIH-Default DMSP

Psychotropic compounds from wastewater contamination affect nervous system development

Dena Weinberger, Murray State University (murraystate.edu)
NIH-Default DMSP

DMSP for "Efficient Red-To-Nir Photo-Uncaging and Applications in Therapy"

Cristo Yanez leon, New Jersey Institute of Technology
NIH-GEN DMSP (Forthcoming 2023)

Rhode Island IDeA Network of Biomedical Research Excellence April 2024

Christopher Hemme, University of Rhode Island (ww2.uri.edu)
NIH-Default DMSP

Increasing Trial Enrollment of Rural Residents in ARDS Clinical Trials

Dustin Krutsinger, University of Nebraska Medical Center (unmc.edu)